Fig. 1

SF3A3 is upregulated and links to unsatisfactory outcomes of HCC patients. (A) Transcription level of SF3A3 (transcript per million) in primary tumor tissues and normal tissues of HCC patients in the UALCAN database. (B) The protein expression of SF3A3 in primary tumor tissues and normal tissues of HCC patients in the UALCAN database. (C) The survival of HCC patients with high SF3A3 expression (n = 90) or medium/low SF3A3 expression (n = 275). (D) SF3A3 mRNA expression in tumor and adjacent tissues from HCC patients using RT-qPCR (n = 30). (E) SF3A3 mRNA expression in HCC cell lines Hep3B and Huh7 and normal hepatocyte cell line THLE-2 using RT-qPCR. All data are expressed as mean ± SD from three experiments. In panel D, significance is determined by paired t-test, and in panel E, significance is determined by one-way ANOVA. **p < 0.01, ****p < 0.0001